MediciNova, Inc. (MNOV) financial statements (2023 and earlier)

Company profile

Business Address 4275 EXECUTIVE SQUARE
LA JOLLA, CA 92037
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments71,43160,03763,79362,31327,99224,11822,077
Cash and cash equivalents71,43160,03763,79362,31327,99224,11822,077
Other undisclosed current assets578680512445337586649
Total current assets:72,00960,71764,30562,75828,32824,70422,726
Noncurrent Assets
Operating lease, right-of-use asset824 400
Property, plant and equipment58564153639120
Long-term investments and receivables    617618650
Long-term investments    617618650
Intangible assets, net (including goodwill)9,6009,6009,6009,6009,6009,6009,600
Goodwill9,6009,6009,6009,6009,6009,6009,600
Other noncurrent assets1152464601111 109
Other undisclosed noncurrent assets4,8004,8004,4004,8004,8004,8004,800
Total noncurrent assets:15,39814,70214,90114,46415,09115,10915,180
TOTAL ASSETS:87,40675,41979,20577,22343,41939,81337,906
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,6251,7921,6552,1922,8811,6301,491
Accounts payable4036174516171,520367171
Accrued liabilities5853524361,5751,3611,2631,320
Employee-related liabilities636823768    
Debt  217    
Other undisclosed current liabilities1,208402356    
Total current liabilities:2,8332,1942,2282,1922,8811,6301,491
Noncurrent Liabilities
Long-term debt and lease obligation  183    
Operating lease, liability  183
Liabilities, other than long-term debt8961,8991,8812291,8963,6513,663
Deferred revenue and credits1,6941,6951,707
Deferred revenue 1,6941,694
Deferred rent credit   27
Deferred tax liabilities, net2022021,9561,956
Deferred income tax liabilities202202 
Other liabilities6953186    
Other undisclosed noncurrent liabilities  191,694   
Total noncurrent liabilities:8961,8992,0821,9231,8963,6513,663
Total liabilities:3,7294,0934,3114,1154,7775,2815,153
Stockholders' equity
Stockholders' equity attributable to parent83,67771,32774,89573,10838,64234,53232,753
Preferred stock      2
Common stock49454442363530
Additional paid in capital476,788454,297444,016429,290380,157364,886352,251
Accumulated other comprehensive loss(99)(88)(93)(93)(95)(96)(103)
Accumulated deficit(393,061)(382,927)(369,073)(356,131)(341,456)(330,293)(319,427)
Total stockholders' equity:83,67771,32774,89573,10838,64234,53232,753
TOTAL LIABILITIES AND EQUITY:87,40675,41979,20577,22343,41939,81337,906

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues4,038      
Cost of revenue
(Cost of Goods and Services Sold)
    (300)(400)(300)
Gross profit:4,038   (300)(400)(300)
Operating expenses(14,253)(14,178)(14,031)(15,587)(13,027)(10,882)(8,822)
Other undisclosed operating income    300400300
Operating loss:(10,216)(14,178)(14,031)(15,587)(13,027)(10,882)(8,822)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(59)(38)(46)(23)12020(15)
Interest and debt expense    (0)(0)(1)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes   940 (0) 
Loss from continuing operations before equity method investments, income taxes:(10,275)(14,217)(14,077)(14,670)(12,907)(10,862)(8,838)
Income (loss) from equity method investments   20(2)(32)34
Other undisclosed income (loss) from continuing operations before income taxes1443611,148(20)232(34)
Loss from continuing operations before income taxes:(10,132)(13,856)(12,929)(14,670)(12,907)(10,862)(8,838)
Income tax expense (benefit)(3)2(13)(5)1,744(4)(7)
Net loss available to common stockholders, diluted:(10,134)(13,854)(12,942)(14,675)(11,163)(10,866)(8,845)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(10,134)(13,854)(12,942)(14,675)(11,163)(10,866)(8,845)
Comprehensive loss:(10,134)(13,854)(12,942)(14,675)(11,163)(10,866)(8,845)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(11)40117(2)
Comprehensive loss, net of tax, attributable to parent:(10,145)(13,849)(12,941)(14,674)(11,162)(10,859)(8,847)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: